AdTech Vendor · B2B SaaS Provider · vs · AdTech Vendor · MarTech Vendor
mediMACH vs Objective Platform
Structured technology and market comparison · 2026
Direct Feature Comparison
mediMACH · vs · Objective PlatformMedia planning and audience analytics software for market-media studies.
SaaS platform for MMM, media planning and budget optimisation.
Analyze all overlapping signals and tech stacks for mediMACH and Objective Platform
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between mediMACH and Objective Platform?
When comparing mediMACH and Objective Platform, both platforms operate within the Measurement & Analytics Platform, Display, Web & Mobile, and AdTech Vendor ecosystem. mediMACH is positioned as Media planning and audience analytics software for market-media studies, whereas Objective Platform focuses on SaaS platform for MMM, media planning and budget optimisation. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to mediMACH and Objective Platform?
When evaluating mediMACH and Objective Platform, enterprise buyers also consider other platforms in Measurement & Analytics Platform, Display, Web & Mobile, and AdTech Vendor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of mediMACH and Objective Platform compare?
mediMACH is headquartered in DE (founded in 2004) with Unknown. Objective Platform is based in NL (founded in 2014) with 50–200 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: mediMACH vs Objective Platform
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
mediMACH
Recent Signals
- ·mediMACH
ma 2026 Audio II Update zum Auswerten mit mediMACH verfügbar
Am 14.10.2026 wurde das Update der ma 2026 Audio II Studie zum Auswerten mit mediMACH verfügbar gemacht.
- ·mediMACH
best for planning 2026 I zum Auswerten mit mediMACH verfügbar
Am 24.09.2026 wurde best for planning 2026 I zum Auswerten mit mediMACH verfügbar gemacht. Zudem wurde der Kinder-Medien-Monitor 2026 am 17.09.2026 verfügbar.
- ·mediMACH
b4t brands 2026-2 zum Auswerten mit mediMACH verfügbar
Am 04.09.2026 wurde b4t brands 2026-2 zum Auswerten mit mediMACH verfügbar gemacht. Zudem sind Vorabtarife PZ 2027 in mediMACH verfügbar.
Objective Platform
Recent Signals
- ·AdzineDisplay, Web & Mobile
European Display Share Falls, CPMs Rise
A recent analysis shows European display advertising’s share of media budgets declined from 17.1% to 12.8% while average CPMs rose 17% from €2.08 to €2.44. The analysis, from Amsterdam-based Objective Platform and based on €1.8 billion of European media investments, suggests advertisers are selecting higher-quality display inventory with better viewability and controllable placements rather than simply cutting display entirely. The article notes alternative explanations (format or client mix, inflation) and frames the findings as a market signal rather than definitive proof. German OVK 2026 projections expect the online display and video market to reach ~€8.2bn in 2026 (display ~€4.0bn; online video ~€4.2bn). IAB Europe benchmarks also show video commanding a majority of display investments and market participants citing media quality as a growth constraint.
- Objective Platform analysis: display share in evaluated media mix fell from 17.1% to 12.8%.
- Average CPMs for display rose 17%, from €2.08 to €2.44.
- Objective Platform says the analysis is based on €1.8 billion of European media investments across multiple brands and markets.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners mediMACH and Objective Platform share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks
